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Organophosphorus compounds (OPCs) have a wide range of applications, from agriculture to warfare. Exposure to these 
brings forward a varied kind of health issues globally. Terbufos is one of the leading OPCs used worldwide. The present 
study investigates the cardiac effect of no observable dose of a metabolite of terbufos, terbufos-sulfone (TS), under non-
diabetic and streptozotocin-induced diabetic condition. One hundred nanomoles per rat (1/20 of LD50) was administered 
intraperitoneally to adult male Wister rats daily for fifteen days. The left ventricle was collected for ultrastructural changes 
by transmission electron microscopy. The blood samples were collected for biochemical tests including RBC 
acetylcholinesterase, creatinine kinase (CK), lactate dehydrogenase (LDH), cholesterol, high density lipoprotein (HDL), 
low density lipoprotein (LDL), triglycerides, ALT, AST, and GGT. The study revealed about 10 % inhibition of RBC-
AChE in two weeks of TS treatment in non-diabetic rats whereas RBC-AChE activity was significantly decreased in 
diabetic TS treated rats. CK, LDH, and triglycerides were significantly higher in diabetic TS treated rats. Electron 
microscopy of the heart showed derangement and lesions of the mitochondria of cardiomyocytes in the TS treated groups. 
The present study concludes that a non-lethal dose of TS causes cardiac lesions which exacerbate under diabetic condition. 
Biochemical tests confirmed the ultrastructural changes. It is concluded that a non-lethal dose of TS may be a risk factor 
for a cardiovascular disease, which may be fatal under diabetic condition.
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Organophosphorus compounds (OPCs) are used in 
agriculture as insecticides, pesticides, helminthicides, 
acaricides, nematocides, and herbicides. Furthermore, they 
are used as a warfare agent and in controlling disease vectors 
for public health purposes. Over the years, the use of OPCs 
has increased dramatically with new applications still being 
developed. To date, there are over 100 different OPCs 
available, with a similar generalised chemical structure. 
Wide accessibility, along with indiscriminate and 
inadvertent use or exposure, may result in intentional 
poisoning or unintentional toxicity and it therefore poses a 
risk to the users and workers involved in their production 
and application. The acute toxicity of different OPCs ranges 
from that of an extremely toxic nerve gas to less than that 
of table salt. Toxicity of all OPCs is due to irreversible 
i n h i b i t i o n  o f  t h e  n e u r o t r a n s m i t t e r  e n z y m e 
acetylcholinesterase (AChE). 
A significant association between OPC exposure and 
toxic effects on different organs has been reported in 
numerous epidemiological studies (1-3). Among several 
toxic manifestations, cardiotoxicity is believed to be one 
of the unrecognised risk factors of OPCs. The effects of 
OPCs on the cardiovascular system are speculative or based 
on individual clinical case reports (4-7). The risk of 
exposure to sub-acute low levels of OPCs for the heart has 
been scarcely addressed and somehow did not garner much 
attention from researchers. Albeit, only electrophysiological 
alterations have been reported but morphological maladies 
have barely been touched upon. The nature of their toxic 
effects is variable ranging from transient to permanent (8). 
It is noteworthy that cardiotoxicity with OPCs may be 
independent of AChE inhibition. For instance, dimethoate 
toxicity in guinea pigs has been reported to cause cardiac 
failure without any effect on AChE inhibition (9). Likewise, 
studies also suggest that toxicity of OPCs causes 
mitochondrial dysfunction mediating a non-cholinergic 
mechanism (10). 
Simultaneously, cardiovascular diseases are increasing 
significantly globally, as is the prevalence and incidences 
of diabetes mellitus (DM), one of the important risk factors 
for cardiovascular diseases. Taken all together, diabetes and 
cardiovascular diseases are predicted to increase even 
further over the next decades. Hence, it is reasonable to 
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predict that exposure to OPCs may have a significant impact 
on the manifestations of cardiotoxicity in patients with 
diabetes and prediabetes much faster than in normal healthy 
individuals. It may be noted that the effect of OPCs under 
diabetic pathological condition is scarcely reported 
(11, 12). 
Therefore, the present study was carried out to 
investigate the effect of sub-acute exposure to terbufos 
sulfone (TS), a highly toxic OPC as per the World Health 
Organization (WHO) classification of insecticides and 
pesticides. Terbufos is registered in more than 20 countries; 
however, its usage has been banned in Europe since 2006. 
The present study was designed to demonstrate whether TS 
relevant to no-observable adverse effect level (NOAEL) 
dose could exacerbate cardiac injury in non-diabetic and 
streptozotocin-induced (STZ) diabetic rats. This study will 
have significant implications because sub-acute exposure 




The original stock of Wistar rats were purchased from 
Harlan Laboratories (Harlan Laboratories, Oxon, England). 
The animals used in the actual experiments were bred at 
our own animal facility from the original stock. Male adult 
rats, weighing 200-250 g were used in the present study. 
The animals were housed in polypropylene cages 
(43x22.5x20.5 cm; six rats per cage) in climate and access 
controlled rooms maintained under standard laboratory 
conditions (temperature: 23±1 °C; humidity: 50±4 %; day/
night cycle: 12h/12h). The rodent pellet diet was procured 
from the Emirates Feed Factory, Abu Dhabi, UAE and water 
was available ad libitum. All the experimental procedures 
were in strict compliance with the protocol approved by the 
institutional animal ethics committee for the care and use 
of laboratory animals (Ethical Approval #A2-13).
Induction of experimental diabetes mellitus
To induce type I diabetes, after an overnight fast, the 
rats were administered a single intraperitoneal (i.p.) 
injection of streptozotocin (60 mg kg-1 body weight) 
prepared freshly in citrate buffer (0.1 mol L-1 pH 4.5) 
solution. The induction of diabetes in rats was confirmed 
measuring random blood glucose levels using a One-Touch 
Glucometer (Lifescan Inc., Milpitas, CA, USA). Animals 
with blood glucose above 235 mg dL-1 were considered 
diabetic and were used further for the experiments.
Experimental design
There were four experimental groups, each containing 
6 rats. Terbufos sulfone (TS) was administered i.p. at a dose 
of 100 nmol per rat (1/20 of LD50) following our previous 
laboratory studies (13). The animals were treated daily for 
two weeks.
Group 1 (G1): Non-diabetic control (saline-treated non-
diabetic rats)
Group 2 (G2): Diabetic control group (No treatment with 
TS)
Group 3 (G3): Non-diabetic group, treated with 100 nmol 
of TS
Group 4 (G4): Diabetic group, treated with 100 nmol of TS
Chemicals
The TS stock solution (100 mmol L-1) was prepared in 
dry acetone. The working solution for the i.p. injection was 
prepared extempore by diluting the stock solution with 
physiological saline. The chemicals, TS and streptozotocin, 
were purchased from Sigma-Aldrich Chemie (Sigma-
Aldrich Chemie GmbH, Steinheim, Germany).
Blood glucose measurement
Random blood glucose was checked on day 8 of each 
week before the injection of TS. Blood samples were 
collected from the tail vein.
RBC-AChE activity
The blood sample for RBC-AChE measurement was 
collected from the tail vein of the animal. The RBC-AChE 
activity was measured in diluted whole blood samples in 
the presence of a selective butyrylcholinesterase inhibitor, 
ethoproprazine, as described previously (14). 
Blood collection for biochemical tests
The blood samples were collected from rats before 
decapitation and were subsequently centrifuged at 2555 g 
for 10 minutes. The obtained serum was then stored frozen 
at -80 °C. The markers for cardiac function viz. myocyte 
Figure 1 Structural formula and some chemical properties of 
terbufos- sulfone
Molecular weight: 320.43 g/mol; empirical formula: C9H21O4PS3
Log P: 2.64; C Log P: 2.58; XLogP3: 2.5
Chemical name/synonyms: Phosphorodithioic acid, S-((1,1-
dimethylethyl)sulfonylmethyl) O,O-diethyl ester, Dithiophosphoric 
acid O,O-diethyl S-[(tert-butylsulfonyl)methyl] ester; S-[(tert-
butylsulfonyl)Methyl] O,O-diethyl phosphorodithioate, S-tert-
butylthiomethyl O,O-diethyl phosphorodithioate
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injury marker enzymes such as lactate dehydrogenase 
(LDH) and creatinine kinase (CK), for lipid profile such as 
cholesterol, triglycerides, high density lipoprotein (HDL), 
low density lipoprotein (LDL), and liver function enzymes 
such as alanine transaminase (ALT), aspartate 
aminotransferase (AST), and gamma-glutamyl transferase 
(GGT) were measured by an autoanalyser (COBAS 
INTEGRA 400 PLUS from Roche Diagnostics, Germany).
Transmission electron microscopy
The left ventricle from the heart of animals of each 
experimental group was cut into small pieces and fixed for 
5 hours in 2.5 % glutaraldehyde in Karnovsky’s solution 
(15). The samples were washed overnight in cacodylate 
buffer (40 °C) and post fixed with 1 % osmium tetroxide 
for 1 hour. The samples were further washed six times in 
cacodylate buffer and dehydrated in ethyl alcohol at graded 
concentrations. They were later treated with propylene 
oxide; two changes of 15 minutes and were then immersed 
in propylene oxide and resin (1:1) for 1 hour followed by 
pure resin overnight. Afterwards, the samples were 
embedded and polymerised at 60 °C for 24 hours. Semi and 
ultrathin sections were cut using a diatome knife procured 
from Agar Scientific, Essex, England. The semi thin sections 
were placed on glass slides and stained with toluidine blue. 
The ultrathin sections were mounted on 3.05 mm 200 mesh 
copper grids and contrast stained first with saturated 
aqueous uranyl acetate for 30 min and then with Renold’s 
lead citrate for 5 minutes. The ultrathin sections were 
viewed under a Philips CM10 transmission electron 
microscope (Eindhoven, The Netherlands).
Statistical analysis
Statistical analysis was performed for all the parameters 
obtained from the experimental groups using SPSS 21.0 
(SPSS Inc., Chicago, IL, USA). To determine the 
significance in comparison to control values, the Mann-
Whitney order rank test was used. The limit of statistical 
significance was set at p<0.05.
RESULTS
Body weight
Figure 2 shows the change in body weight of 
experimental animals after the first and second weeks of 
saline (controls) and TS treatment. The non-diabetic 
animals increased body weight over time irrespective of 
whether treated with saline or TS. The diabetic animal 
groups decreased their body weight. This decrease was 
more conspicuous in the TS treated than in the saline treated 
group. However, the change was not found statistically 
significant compared to the pre-treatment or first-week body 
weight.
Blood glucose
Random blood glucose levels across G1 to G4, over a 
period of two weeks, are depicted in Figure 3. The average 
two-week blood glucose levels in G1 and G2 (control 
groups) were 100±9 mg dL-1 and 473±72 mg dL-1, 
respectively. The average two-week blood glucose level in 
G3 was 100±8 mg dL-1. The mean blood glucose level for 
diabetic rats treated with TS100 (G4) was 511±29 mg dL-1 
over the two-week period. This increase was statistically 
significant (p<0.05) compared to the pre-treatment value 
(432±29 mg dL-1). 
RBC-Acetylcholinesterase
The activity of RBC-AChE enzyme was determined as 
a percentage of baseline and is depicted in Figure 4. The 
Figure 2 Changes in body weight of different experimental groups
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Figure 3 Changes in blood glucose level over weeks in different experimental groups
Figure 4 Changes in RBC-AChE over weeks in control and TS treated groups
*Statistically significant at p≤0.05; Mann-Whitney order rank test
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intraperitoneal injection of 100 nmol of TS administered 
to non-diabetic rats (G2) did not produce a significant 
change in the RBC-AChE activity. The same dose in STZ-
induced diabetes (G4) produced a sharp and statistically 
significant decrease (p<0.05) in week 1 (38 %±18) and 
week 2 (11 %±3). The diabetic control group (G3) showed 
a moderate decrease which was statistically not significant.
The ultrastructure of the heart (transmission electron 
microscopy)
The ultrastructure of the heart by transmission electron 
microscopy is represented in Figure 5. A representative 
image of the ultrastructure of the heart of non-diabetic 
control rats is represented in Figure 5A. Myofibrils were 
observed intact with thick and definite architecture and 
linearly arranged mitochondria. Figure 5C shows the 
ultrastructure of the heart of non-diabetic TS treated rats. 
A distorted architecture of myofibrils, large inter-
myofibrillar spaces and swollen mitochondria are 
conspicuous and are the effect of TS treatment. Figure 5B 
shows the diabetic control group. Thin myofibril, deranged 
mitochondria, and inter-myofibrillar spaces are a 
characteristic pathological effect of diabesity. The 
mitochondria (m) of the cardio myocytes of the heart of 
diabetic rats treated with TS (Figure 5D) contain deranged 
mitochondria (m) and large muscle inter-fibre spaces. 
Mitochondrial lesions were more conspicuous in diabetic 
rats (Figure 5D) when compared to those of the non-diabetic 
and diabetic control groups (Figure 5A & B), and TS treated 
non-diabetic (Figure 5C) rats. A damaged architecture of 
myofibrils was clearly observable between the TS treated 
and non-treated groups though diabetes itself damages the 
heart structure.
CK and LDH
Table 1 shows the creatine kinase (CK) and lactate 
dehydrogenase (LDH) levels in the control and TS treated 
groups after two weeks of treatment. CK and LDH levels 
were found significantly elevated (p<0.05) in the diabetic 
TS treated groups, indicating a cardiac manifestation of TS 
treatment.
Lipid profile
Table 2 shows the measurement of cholesterol, HDL, 
LDL, triglycerides, ALT, AST, and GGT in the serum of 
the treated and non-treated groups. The non-diabetic TS 
treated groups did not show statistical significance (Table 
3) in the alteration of the tested parameters when compared 
to their corresponding non-diabetic saline control except 
for AST, which decreased significantly. However, diabetic 
rats treated with TS showed marked and statistically 
significant (p<0.05) changes in all the tested parameters 
except for ALT, which was found to be non-significantly 
different than in the diabetic saline control group. Among 
all the parameters of the lipid profile, triglycerides markedly 
surged in the diabetic TS treated group (mean±SD: 
1.61±0.79) compared to the diabetic and non-diabetic 
controls (mean±SD: 0.60±0.12, 0.90±0.40 respectively).
DISCUSSION
The present study demonstrates that even a relatively 
non-lethal dose of terbufos sulfone and sub-acute exposure 
to it causes toxic effects to the heart of non-diabetic and 
STZ-induced diabetic rats. Terbufos belongs to an extremely 
toxic group of OPCs as per the WHO’s classification of 
hazardous chemicals (16) and its metabolites are also 
Table 2 Blood lipid profile in different experimental groups. *p≤0.05; Mann-Whitney order rank test. *Statistically significant when 
compared to non-diabetic saline control (p<0.05). **Statistically significant when compared to diabetic saline control (p<0.05)







































































































 saline control -- 0.925 0.701 0.062
Non-diabetic
TS treated 0.925 -- 0.019 0.019
Diabetics saline control 0.701 0.019 -- 0.023
Diabetic
TS treated 0.062 0.019 0.023 --
HDL
Non-diabetics saline 
control -- 0.715 0.008 0.144
Non-diabetic
TS treated 0.715 -- 0.199 0.199
Diabetics saline control 0.008 0.199 -- 0.004
Diabetic
TS treated 0.144 0.199 0.004 --
LDL
Non-diabetics saline 
control -- 0.142 0.117 0.006
Non-diabetic
TS treated 0.142 -- 0.020 0.020
Diabetics saline control 0.117 0.020 -- 0.004
Diabetic
TS treated 0.006 0.020 0.004 --
Triglyceride
Non-diabetics saline 
control -- 0.715 0.045 0.068
Non-diabetic
TS treated 0.715 -- 0.016 0.016
Diabetics saline control 0.045 0.016 -- 0.006
Diabetic
TS treated 0.068 0.016 0.006 --
ALT
Non-diabetics saline 
control -- 0.647 0.010 0.035
Non-diabetic
TS treated 0.647 -- 0.030 0.030
Diabetics saline control 0.010 0.030 -- 0.150
Diabetic
TS treated 0.035 0.030 0.150 --
AST
Non-diabetics saline 
control -- 0.011 0.006 0.006
Non-diabetic
TS treated 0.011 -- 0.006 0.006
Diabetics saline control 0.006 0.006 -- 0.016
Diabetic
TS treated 0.006 0.006 0.016 --
GGT
Non-diabetics saline 
control -- 0.219 0.402 0.005
Non-diabetic
TS treated 0.219 -- 0.003 0.003
Diabetics saline control 0.402 0.003 -- 0.007
Diabetic
TS treated 0.005 0.003 0.007 --
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Figure 5 Electron microscopic changes in the heart tissue. Scale bar=0.5 µm.
A=non-diabetic control; B=diabetic control; C=non-diabetic TS treated, and D=diabetic rat treated with TS; m=mitochondrion
B
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persistent in the environment (http://www.abcbirds.org/
abcprograms/policy/toxins/profiles/terbufos.html). TS is 
the active metabolite of terbufos, the fourth most frequently 
used pesticide in the USA, reported for its use in fish kill 
incidents, which is also suggestive of its presence in the 
food chain (17). To the best of our knowledge and based 
on the available literature, no data on the cardiovascular 
condition following sub-acute exposure to this compound 
has been reported. Hundreds of different OPCs share a 
common mechanism of action but are toxicologically 
different one from the other, ranging from deadly poison 
nerve agents to those with virtually no toxic potential (18). 
According to the website Scorecard (19), the list of more 
than 500 cardiovascular toxins causing different types of 
cardiovascular complications contains only few OPCs. This 
list reflects the paucity of studies with OPCs. Asymptomatic 
low-level exposure to OPCs has been reported to cause 
various health effects including cardiac lesions (8, 20, 21). 
Different individual toxicokinetics of OPCs necessitates 
investigating the effect on the heart under normal and 
diabetic conditions (22). The cardiovascular manifestation 
of OPC poisoning is mainly attributed to acute poisoning 
(23–27), which comprises bradycardia or tachycardia or 
impaired heart rate. There are reports showing an increased 
level of creatine kinases and lactate dehydrogenases, besides 
myocardial necrosis (28). The results of the present study 
reveal that TS causes a leakage of myocyte injury marker 
enzymes into the serum, as evidenced by the elevated levels 
of serum CK and LDH. The structural change in the heart 
was further correlated with the myocyte injury marker 
enzymes’ leakage from cardiomyocytes to the serum. Abdou 
et al. (29) reported increased LDH and histologically large 
areas of degenerating muscle fibres with an evident loss of 
transverse striations and wide inter-fascicular spaces when 
treated with diazinon, an OPC. Velmurugan (30) used 1/50th 
of LD50 dosage of monochrotophos against Wister rats and 
found elevated LDH and CK-MB in the blood plasma along 
with signs of nonspecific inflammatory changes and oedema 
between muscle fibres of the heart. 
The present study also investigated ultrastructural 
changes following the administration of a non-lethal dose 
of TS to non-diabetic and STZ-induced diabetic rats. 
Ultrastructural changes after acute OPC poisoning have 
been reported by numerous clinical case studies (31–34). 
We also observed similar cardiac lesions in diabetic rats 
with sub-acute and apparently non-lethal exposure to TS. 
The injurious effect on the heart in diabetic rats was further 
confirmed by low HDL and high triglycerides. These 
observations are in line with other previous studies which 
report that exposure to repeated doses of profenfos, an OPC, 
significantly increased LDH and CK enzymes (35). The 
probable reason for this leakage could be cell death as 
Razavi et al. (36) reported with sub-chronic exposure to 
diazinon, an organophosphate. In the present study, we also 
observed that TS administration led to a structural 
impairment of the mitochondrion in non-diabetic TS treated 
rats, but the lipid profile was not significantly affected. This 
observation was supported by a previous study wherein a 
higher but non-lethal dose of 20 mg kg-1 body weight of 
diazinon administered for four weeks did not reveal a 
change in the cholesterol and triglyceride levels (37). 
OPC elicits its toxicity by inhibiting acetylcholinesterase. 
The severity of poisoning depends upon the extent of AChE 
inhibition and consequent cholinergic crises. This may be 
correlated with the observation that inhibition of AChE was 
severe in diabetic rats at the end of the second week and it 
resembled acute toxicity. The effect of anticholinesterases 
on the heart is mainly attributed to acute toxicity, especially 
the delayed or late phase effect (5). Different mechanisms 
and pathways have been reported to be involved in the 
cardiotoxicity of acute OPC poisoning. One of the studies 
suggests that morphologic damage may be instigated by 
uninterrupted vagus nerve stimulation of the accumulated 
acetylcholine (5). Herein, the magnitude of myocardial 
damage correlated with the duration of exposure. It has also 
been found that cardiac damage may be independent of the 
extent of AChE inhibition contrary to the high level 
inhibition of AChE in acute poisoning. Since acetylcholine 
receptors have a high binding capacity for calcium ions 
(38), the disorder of cellular morphology may be ascribed 
to a massive influx of Ca2+ into the cytoplasm. The results 
also signify that TS even after two weeks has a potential to 
raise triglyceride levels, cause myocyte injury and 
subsequent myocardial injury. Interestingly, the changes 
observed were irrespective and independent of the degree 
of AChE inhibition, as it was observed to be high in diabetes 
and low in non-diabetic rats. This suggests that occupational 
exposure to TS, even at low doses, may pose a risk in those 
who are prone to develop diabetes and can worsen cardio-
toxic manifestations in diabetics. In addition, ultra-structural 
studies may be a vital tool in identifying the non-lethal dose 
associated cardiac effect, since biochemical changes may 
be not evident at such dose or can manifest after very long 
exposure. Considering the high rise of diabetes and 
cardiovascular diseases, the exposure to TS may impact 
cardiovascular health, worsen the disease condition and 
accelerate progression. 
CONCLUSION
TS at a relatively non-lethal dose may be associated 
with cardiovascular complications including myofibril 
degeneration, wide inter-fascicular spaces, and mitochondria 
mutilation. The impact may become exacerbated under 
diabetic condition, which may lead to mortality and 
morbidity. The effect may be independent of ACh inhibition 
as observed in non-diabetic rats or might be related to ACh 
inhibition, as was seen in diabetic rats.
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Terbufos sulfon pogoršava srčane lezije u štakora koji boluju od dijabetesa: studija subakutne toksičnosti
Organofosforni spojevi (eng. Organophosphorous Compounds - OPCs) imaju široku primjenu, od one u poljoprivredi 
do one u vojne svrhe. Izlaganje takvim spojevima izaziva niz različitih zdravstvenih problema od globalnog značaja. 
Terbufos je jedan od vodećih OPC-a koji se koriste diljem svijeta. U ovom je istraživanju na modelu štakora bez dijabetesa 
i sa streptozotocinom izazvanim dijabetesom ispitivan metabolit terbufos-sulfon (TS) u najvišoj dozi koja ne izaziva 
učinak te njezin utjecaj na srce. Odrasli mužjaci štakora soja Wistar dobivali su petnaest dana dnevnu dozu od 
100 nmol štakor-1 (1/20 LD50) intraperitonealno. Transmisijskim elektronskim mikroskopom istražene su ultrastrukturne 
promjene lijeve klijetke. Na krvnim uzorcima provedeni su biokemijski testovi, uključujući aktivnost acetilkolinesteraze 
u crvenim krvnim stanicama, razinu kreatinin kinaze (CK), laktat dehidrogenaze (LDH), kolesterola, lipoproteina visoke 
gustoće (HDL), lipoproteina niske gustoće (LDL), triglicerida, ALT, AST i GGT. Istraživanjem je otkriveno oko 10 % 
inhibicije AChE-a u crvenim krvnim stanicama nakon dva tjedna izlaganja štakora bez dijabetesa TS-u, dok je u štakora 
s dijabetesom aktivnost AChE-a bila značajno smanjena. Razine CK, LDH i triglicerida bile su značajno više u TS 
tretiranim štakorima s dijabetesom. Elektronsko-mikroskopska analiza srca upućuje na narušenu strukturu i lezije u 
mitohondrijima u kardiomiocitima skupina štakora koji su tretirani TS-om. Zaključuje se da nesmrtonosna doza TS-a 
uzrokuje srčane lezije koje se pogoršavaju u prisutnosti dijabetesa. Biokemijski testovi  potvrdili su ultrastrukturne 
promjene. Navedena doza TS-a može biti rizični čimbenik za kardiovaskularne bolesti, koje se mogu pokazati smrtonosnima 
uz istovremeno postojanje dijabetesa.
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